International Clinical Trial: A clinical study to evaluate the safety and effect of PRA-523, an investigational drug, compared to a drug with no active ingredient for the treatment of itch caused by atopic dermatitis

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN63487177) titled 'A clinical study to evaluate the safety and effect of PRA-523, an investigational drug, compared to a drug with no active ingredient for the treatment of itch caused by atopic dermatitis' on Jan. 21.

Study Type: Interventional

Study Design: Double-blind, randomized, adaptive, vehicle controlled first-in-human phase 1-2a trial (Efficacy, Safety, Treatment)

Primary Sponsor: Praeventix, Inc.

Condition: Pruritus secondary to atopic dermatitis Skin and Connective Tissue Diseases

Intervention: Participants will be randomized to the active drug or a placebo with no active drug (2:1) via an IRT System and will apply...